Table 3.
Usage of HbV as a CO carrier for anti-inflammatory and anti-oxidative effect.
Application | Animal Species | Brief Description of Main Results | Reference |
---|---|---|---|
Hemorrhagic shock | Wistar rats | Hemorrhagic shocked rats were resuscitated with CO-HbV suspended in HSA. AST and ALT levels were reduced as compared to O2-HbV injection | [48] |
Pulmonary fibrosis | Sea-ICR mice | Bleomycin-induced pulmonary fibrosis mice that received CO-HbV showed suppression of progression of fibrosis and improved respiratory function | [49] |
Colitis | Sea-ICR mice | Dextran sulfate sodium-induced colitis model mice receiving CO-HbV improved colitis symptoms, colonic histopathological changes and the duration of survival compared to both saline and O2-HbV administration | [50] |
Pancreatitis | BALB/cN mice | Pancreatitis model mice were prepared with a choline-deficient ethionine-supplemented diet. CO-HbV inhibited the production of systemic proinflammatory cytokines, neutrophil infiltration, and oxidative injuries | [51] |